Skip to Main Content

Author Details

Brian P Hobbs
Dell Medical School, University of Texas at Austin
2008
112
34
PMIDPaper TitleJournal TitlePublished Year
37652304Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy.Int J Radiat Oncol Biol Phys2024
34341905Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors.Invest New Drugs2022
35537102Basket Trials: Review of Current Practice and Innovations for Future Trials.J Clin Oncol2022
35385345Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts.JCO Precis Oncol2022
36089921Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.JTO Clin Res Rep2022
36186544Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.Contemp Clin Trials Commun2022
35128970Bayesian basket trial design with false-discovery rate control.Clin Trials2022
34888892Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response.Stat Med2022
35267613The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer.Cancers (Basel)2022
35229311A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy.Med Phys2022
34755388A group-sequential randomized trial design utilizing supplemental trial data.Stat Med2022
33096027Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.Lancet Respir Med2021
34665662Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning.JCO Clin Cancer Inform2021
34534613Current status and application of proton therapy for esophageal cancer.Radiother Oncol2021
34448657A survival mediation model with Bayesian model averaging.Stat Methods Med Res2021
34036293Increased Incidence of Venous Thromboembolism with Cancer Immunotherapy.Med2021
34061563Moving Beyond 3+3: The Future of Clinical Trial Design.Am Soc Clin Oncol Educ Book2021
33436486Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival.J Immunother Cancer2021
33393051Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis.Ann Surg Oncol2021
33267746Statistical design considerations for trials that study multiple indications.Stat Methods Med Res2021
30672395A functional model for classifying metastatic lesions integrating scans and biomarkers.Stat Methods Med Res2020
32053149HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer.JAMA Oncol2020
31862960Do persons with chronic myeloid leukaemia have normal or near normal survival?Leukemia2020
32712894The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis.Ann Surg Oncol2020
32658656Randomized Controlled Trials.Chest2020
32961553Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes.Blood2020
32821110Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database.Breast Cancer (Auckl)2020
32698967Comparing Radiation Modalities with Trimodality Therapy Using Total Toxicity Burden.Int J Radiat Oncol Biol Phys2020
32528101Histology-agnostic drug development - considering issues beyond the tissue.Nat Rev Clin Oncol2020
32434711Elucidating Determinants of Survival Disparities Among a Real-world Cohort of Metastatic Breast Cancer Patients: A National Cancer Database Analysis.Clin Breast Cancer2020
32160096Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.J Clin Oncol2020
31479748Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC.J Thorac Oncol2020
30359480Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study.Cancer2019
35100726Basket Designs: Statistical Considerations for Oncology Trials.JCO Precis Oncol2019
31743629Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research.Ethics Hum Res2019
31792304Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis.Sci Rep2019
30037304Estimating mean local posterior predictive benefit for biomarker-guided treatment strategies.Stat Methods Med Res2019
31292802Phase II study of Dovitinib in recurrent glioblastoma.J Neurooncol2019
31427205Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.Lancet Oncol2019
31097024A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy.J Immunother Cancer2019
30947241Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study.PLoS One2019
30822350Time to initial cancer treatment in the United States and association with survival over time: An observational study.PLoS One2019
30962976The promise and challenges of deep learning models for automated histopathologic classification and mutation prediction in lung cancer.J Thorac Dis2019
30786040Bayesian personalized treatment selection strategies that integrate predictive with prognostic determinants.Biom J2019
26763586Controlled multi-arm platform design using predictive probability.Stat Methods Med Res2018
30082477A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.Clin Cancer Res2018
30079369Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.Int J Part Ther2018
29984488Bayesian basket trial design with exchangeability monitoring.Stat Med2018
29949418Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis.AJR Am J Roentgenol2018
31439980Spatial Bayesian modeling of GLCM with application to malignant lesion characterization.J Appl Stat2018
  • 1 - 50 of 112

Recommended Authors

David Geffen School of Medicine, University of California los angeles
Career Start Year 2018
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 2018
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 2018
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2018
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2017
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2013
Number of shared co-authors 14
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2010
Number of shared co-authors 0
University of Toronto
Career Start Year 2010
Number of shared co-authors 0
University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 6
Center for Statistics, Hasselt University
Career Start Year 2007
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Duke University
Career Start Year 2005
Number of shared co-authors 4
117902Beijing TongRen Hospital, Capital Medical University
Career Start Year 2004
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center.
Career Start Year 2002
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 11
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1994
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 0
New York University.
Career Start Year 1987
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 11
Harvard Medical School
Career Start Year 1985
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1975
Number of shared co-authors 0

Collaborators

University of Texas MD Anderson Cancer Center
Co-authored papers 17
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Cleveland Clinic
Co-authored papers 2
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 1
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Co-authored papers 1
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 1
University of North Carolina
Co-authored papers 1
Stanford University
Co-authored papers 1
MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
School of Public Health, The University of Texas Health Science Center at Houston
Co-authored papers 1
Cleveland Clinic and Lerner College of Medicine at Case Western Reserve University
Co-authored papers 1
University of Texas Health Science Center at Houston
Co-authored papers 1